Staphylococcal protein A (SpA) (SpA)

Staphylococcal protein A (SpA) is a key virulence factor anchored to the cell wall of Staphylococcus aureus, consisting of five highly homologous immunoglobulin-binding domains (E, D, A, B, and C). Domain E, located at the N-terminus, plays a critical role in the pathogen's immune evasion strategy by binding to the Fc region of host IgG with high affinity, which orients antibodies away from phagocytic receptors and prevents opsonophagocytosis. Additionally, SpA acts as a B-cell superantigen by binding to the VH3 family of B-cell receptors, triggering polyclonal expansion and subsequent apoptosis of B-cells, which impairs the host's ability to mount a specific adaptive immune response. Due to its central role in pathogenesis, SpA is a primary target for the development of therapeutic monoclonal antibodies and vaccines aimed at neutralizing its immunosuppressive effects during invasive S. aureus infections. In biotechnology, the E domain and its counterparts are extensively utilized in affinity chromatography for the purification of monoclonal antibodies.

Other names

Protein ASpA domain EImmunoglobulin-binding protein AStaphylococcus aureus surface protein A

Monoclonal antibodies target the immunoglobulin-binding domains (including domain E) of SpA to neutralize its ability to bind the Fc region of host IgG, thereby restoring opsonophagocytic killing by immune cells and preventing B-cell apoptosis induced by SpA's superantigen activity.